Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
A quiet pivot from consumer devices to AI infrastructure has propelled this former smartphone maker into the spotligh...
A practical guide to interpreting FRPH's Q2 2025 earnings transcript. Learn what to watch, how numbers fit the story,...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
Insider moves can spark questions about a regional bank's future. This guide explains what a director selling shares ...
A closer look at how Netflix blends AI-enabled production with patient capital. This isn't a new trick—it's a 25-year...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Nordson (NDSN) is set for a pivotal 2025 earnings year. This guide breaks down the levers that could move profits, ho...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...